In randomized managed trials, There's two treatment possibilities at the moment deemed the conventional of treatment in Guillain-Barré syndrome (GBS). These involve both intravenous immunoglobulin (IVIG) or plasma https://ksnr.org.in/guillain-barre-syndrome/